A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral TP-271 in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 03 May 2018
At a glance
- Drugs TP 271 (Primary)
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Adverse reactions
- Sponsors Tetraphase Pharmaceuticals
- 03 May 2018 According to the Tetraphase Pharmaceuticals media release, company expect to complete this trial in 2H 2018.
- 04 Apr 2018 Status changed from not yet recruiting to recruiting.
- 07 Mar 2018 New trial record